News Search Results
Aug 28, 2025, 07:03 ET Veeva Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation
Veeva Systems (NYSE: VEEV) today announced a collaboration with Amgen to advance clinical trial innovation. As a global leader in biotechnology, Amgen will employ the Veeva Clinical Platform
More news about: Veeva Systems
Aug 28, 2025, 07:03 ET Veeva Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation
Veeva Systems (NYSE: VEEV) today announced a collaboration with Amgen to advance clinical trial innovation. As a global leader in biotechnology, Amgen will employ the Veeva Clinical Platform
More news about: Veeva Systems
Aug 28, 2025, 07:00 ET SmartLabs and Sonrai Launch Exclusive Partnership to Bring Advanced AI Capabilities to SmartLabs' Member Companies
Sonrai Discovery, expedites identifying and developing drug or therapeutic targets, improving patient outcomes through AI. The company partners with biotechnology and pharmaceutical companies to manage and analyze their precision medicine data. By leveraging Sonrai Discovery, these companies can confidently
More news about: SmartLabs
Aug 28, 2025, 07:00 ET SmartLabs and Sonrai Launch Exclusive Partnership to Bring Advanced AI Capabilities to SmartLabs' Member Companies
Sonrai Discovery, expedites identifying and developing drug or therapeutic targets, improving patient outcomes through AI. The company partners with biotechnology and pharmaceutical companies to manage and analyze their precision medicine data. By leveraging Sonrai Discovery, these companies can confidently
More news about: SmartLabs
Aug 28, 2025, 06:59 ET Q32 Bio to Participate in the 2025 Wells Fargo Healthcare Conference
Aug. 28, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today announced that
More news about: Q32 Bio
Aug 28, 2025, 06:12 ET More than 500 MNCs offered record 5000 Job Offers to Engineering students of Chandigarh University in 2024-25
Wonder Cement. In Biotechnology and Food Technology, 75% students of Chandigarh University received job offers from over 20 companies during the campus placement drive with the highest package of Rs 7 LPA. The top recruiters for Biotechnology and Food Technology
More news about: Chandigarh University
Aug 28, 2025, 03:30 ET Leucid Bio to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
Aug. 28, 2025 /PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies using the Company's proprietary lateral CAR platform,
More news about: Leucid Bio
Aug 27, 2025, 19:45 ET Ascletis Announces Favorable and Differentiated Pharmacokinetic Profile of ASC30 Oral Once-Daily Tablet in Its U.S. Phase Ib Multiple Ascending Dose Study
patent protection until 2044 without patent extensions. About Ascletis Pharma Inc. Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Aug 27, 2025, 18:40 ET BIOVAXYS ANNOUNCES UNSECURED CONVERTIBLE DEBENTURE OFFERING AND CANCELLATION OF BROKERED LIFE OFFERING
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Aug 27, 2025, 17:31 ET Diffuse Large B-cell Lymphoma Market to Grow at a CAGR of 13% by 2034 in Leading Markets (US, EU4, UK, and Japan) | DelveInsight
Pharmaceuticals, Genmab, IDP Discovery Pharma S.L., Immunitas Therapeutics, Monte Rosa Therapeutics, SymBio Pharmaceuticals, Eagle Pharma, AVM Biotechnology, Autolus Therapeutics, Kymera Therapeutics, Otsuka Pharmaceutical, Caribou Biosciences, Adicet Bio, Gilead Sciences, Xynomic Pharmaceuticals, Amgen,
More news about: DelveInsight Business Research, LLP
Aug 27, 2025, 15:28 ET The Galien Foundation Announces 2025 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
Shenzhen ReeToo Biotechnology Co., Ltd.
More news about: The Galien Foundation
Aug 27, 2025, 15:17 ET CAGE Bio Announces Collaboration to Advance First-in-Class Treatments for Cutaneous Graft versus Host Disease
value of CAGE Bio's ionic liquid technology for developing critical therapies for patients." About CAGE Bio Inc. CAGE Bio Inc. is a biotechnology company dedicated to developing innovative therapies for immune-mediated diseases using its proprietary ionic liquid technology platform. The company's
More news about: CAGE Bio Inc.
Aug 27, 2025, 12:45 ET Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
Aug. 27, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it has entered into an agreement to acquire Advent
More news about: Northwest Biotherapeutics, Inc.
Aug 27, 2025, 12:39 ET Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
Aug. 27, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it has entered into an agreement to acquire Advent
More news about: Northwest Biotherapeutics, Inc.
Aug 27, 2025, 10:43 ET 晶泰控股發佈 2025 年上半年業績報告
備突破性治療潛力的 PRMT5 抑制劑 PE-0260，目前，智擎生技已完成IND申報，並已經啟動了臨床試驗。我們與孵化公司希格生科合作的全球首款瀰漫性胃癌靶向藥物，獲得「醫藥界的諾貝爾獎」蓋倫獎（Prix Galien Awards) 最佳生物技術產品獎（Best Biotechnology Product）提名，我們獲提名的管線是本次唯一來自亞洲的管線，也是該獎項50多年來 第四次 提名中國公司。得益於前期訂單的高質量交付，抗體業務在 2025 年上半年實現收入的大幅增長, 達到 2024 年全年收入的近二倍。 抗體業務已與多家國際知名藥企開展深度合作，業務角色也由服務提供商逐步升級為平台型的聯合開發者，顯著提升了單一客戶的生命週期價值。晶泰AI賦能孵化企業萊芒生物，兩條管線取得重要進展。（1）其代謝增強型CD19
More news about: 晶泰科技
Aug 27, 2025, 10:40 ET Harbour BioMed Reports 2025 Interim Results
In February 2025, Harbour BioMed entered into a strategic collaboration with Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, to accelerate the discovery of novel therapeutic antibodies by combining complementary strengths in antibody discovery
More news about: Harbour BioMed
Aug 27, 2025, 10:23 ET XtalPi Holdings Announces 2025 Interim Results
co-developed with incubated company Signet Therapeutics, was nominated for the prestigious Prix Galien Award for Best Biotechnology Product, often hailed as the "Nobel Prize of the pharmaceutical industry". This was the only Asian pipeline nominated this year and only the fourth
More news about: XtalPi Inc.
Aug 27, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
[Click here for information about joining the class action] Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical needs in the U.S. The Company is developing, among other
More news about: Pomerantz LLP
Aug 27, 2025, 09:00 ET BioMarin to Participate in Upcoming Investor Conferences
available through the Company's website for a limited time following the conference. About BioMarinBioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San
More news about: BioMarin Pharmaceutical Inc.
Aug 27, 2025, 09:00 ET Evommune Initiates Phase 2b Trial of its Oral MRGPRX2 Antagonist, EVO756, in Adults with Moderate to Severe Atopic Dermatitis
Calif., Aug. 27, 2025 /PRNewswire/ -- Evommune, Inc., a clinical stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced the enrollment
More news about: Evommune, Inc
Aug 27, 2025, 09:00 ET Portfolia Launches Women's Health Fund IV, Building on its 46-Company Women's Health Portfolio
Fund IV's debut investment is in Gameto, a clinical-stage biotechnology company reprogramming female cells to transform fertility and hormonal care. Portfolia's investment is part of Gameto's recently announced
More news about: Portfolia
Aug 27, 2025, 08:30 ET Analytical Platform for Rapid, Reliable mRNA Modality Analytics, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 27, 2025, 08:30 ET Hot Melt Extrusion: Accelerating Drug Development for Poorly Soluble APIs, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 27, 2025, 08:30 ET Scalable VHH and Peptide Secretion Platform Using C. glutamicum, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 27, 2025, 08:30 ET Advancing the Next Parkinson's Disease Breakthrough: Keys to Successful Clinical Trials, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks